Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.
Saved in:
| Title: | Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. |
|---|---|
| Authors: | Rizzello C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy., Sangaletti S; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Ratti C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Milani M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Via F. Chiesa 5, 6500, Bellinzona, Switzerland.; Oncology Institute of Southern Switzerland, Ente Ospedialiero Cantonale, Via A. Gallino 12, 6500, Bellinzona, Switzerland., Tripodo C; Tumor Immunology Unit, Department of Health Science, University of Palermo School of Medicine, Palermo, Italy.; FIRC Institute of Molecular Oncology (IFOM), Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. claudia.chiodoni@istitutotumori.mi.it., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy. mariopaolo.colombo@istitutotumori.mi.it. |
| Source: | Molecular cancer [Mol Cancer] 2022 Dec 12; Vol. 21 (1), pp. 215. Date of Electronic Publication: 2022 Dec 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-022-01687-6 |
